These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29291164)

  • 1. Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer.
    Sonali ; Viswanadh MK; Singh RP; Agrawal P; Mehata AK; Pawde DM; Narendra ; Sonkar R; Muthu MS
    Nanotheranostics; 2018; 2(1):70-86. PubMed ID: 29291164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
    Muthu MS; Leong DT; Mei L; Feng SS
    Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advancement of Nanotheranostics in Cancer Applications.
    Parveen S; Abira R; Paikray S; Sahoo L; Tripathy NS; Dilnawaz F
    Curr Drug Deliv; 2024 May; ():. PubMed ID: 38812425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent nanotheranostic approaches in cancer research.
    Gupta D; Roy P; Sharma R; Kasana R; Rathore P; Gupta TK
    Clin Exp Med; 2024 Jan; 24(1):8. PubMed ID: 38240834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/photodynamic therapy and simultaneous MR/UCL imaging.
    Fan W; Shen B; Bu W; Chen F; He Q; Zhao K; Zhang S; Zhou L; Peng W; Xiao Q; Ni D; Liu J; Shi J
    Biomaterials; 2014 Oct; 35(32):8992-9002. PubMed ID: 25103233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotheranostics for Cancer Therapy and Detection: State of the Art.
    Paliwal SR; Kenwat R; Maiti S; Paliwal R
    Curr Pharm Des; 2020; 26(42):5503-5517. PubMed ID: 33200696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J; Torres-Suárez AI
    Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotheranostic Pluronic-Like Polymeric Micelles: Shedding Light into the Dark Shadows of Tumors.
    Domingues C; Alvarez-Lorenzo C; Concheiro A; Veiga F; Figueiras A
    Mol Pharm; 2019 Dec; 16(12):4757-4774. PubMed ID: 31633939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-based cancer nanotheranostics: retrospectives of multi-functionalities and pharmacokinetics.
    Han N; Yang YY; Wang S; Zheng S; Fan W
    Curr Drug Metab; 2013 Jul; 14(6):661-74. PubMed ID: 23869810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimers based cancer nanotheranostics: An overview.
    Saluja V; Mishra Y; Mishra V; Giri N; Nayak P
    Int J Pharm; 2021 May; 600():120485. PubMed ID: 33744447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotheranostics for Diagnosis and Treatment of Breast Cancer.
    Patel P; Kumar K; Jain VK; Popli H; Yadav AK; Jain K
    Curr Pharm Des; 2023; 29(10):732-747. PubMed ID: 36999427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Nanomedicine in Brain Tumor Therapy: Nanocarrierbased Drug Delivery Platforms, CChallenges, and Perspectives.
    Verma R; Rao L; Kumar H; Bansal N; Deep A; Parashar J; Yadav M; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2023 Nov; ():. PubMed ID: 37937554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Magnetic Nanoparticles in Cancer Nanotheranostics.
    Ferreira M; Sousa J; Pais A; Vitorino C
    Materials (Basel); 2020 Jan; 13(2):. PubMed ID: 31936128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab guided nanotheranostics: A lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy.
    Parhi P; Sahoo SK
    J Colloid Interface Sci; 2015 Aug; 451():198-211. PubMed ID: 25897856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on (Hydro)Porphyrin-Loaded Polymer Micelles: Interesting and Valuable Platforms for Enhanced Cancer Nanotheranostics.
    Nascimento BFO; Pereira NAM; Valente AJM; Pinho E Melo TMVD; Pineiro M
    Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30769938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities.
    Siafaka PI; Okur NÜ; Karantas ID; Okur ME; Gündoğdu EA
    Asian J Pharm Sci; 2021 Jan; 16(1):24-46. PubMed ID: 33613728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotheranostics, a future remedy of neurological disorders.
    Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
    Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.